• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

加纳夸贝东地区 10 年结核登记回顾性研究:结核-艾滋病毒合并感染的流行率、治疗结局和决定因素。

Prevalence, treatment outcomes and determinants of TB-HIV coinfection: a 10-year retrospective review of TB registry in Kwabre East Municipality of Ghana.

机构信息

Department of Epidemiology and Biostatistics, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana

Department of Public Health, Ghana Health Service, Accra, Ghana.

出版信息

BMJ Open. 2023 Mar 22;13(3):e067613. doi: 10.1136/bmjopen-2022-067613.

DOI:10.1136/bmjopen-2022-067613
PMID:36948553
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10040042/
Abstract

OBJECTIVE

To assess the prevalence, treatment outcomes and determinants of tuberculosis (TB)-HIV coinfection in Ghana.

STUDY DESIGN

A retrospective review of TB case register for Kwabre East Municipality was conducted for the period 2010-2020 to identify TB-HIV coinfections.

SETTING

462 patients with TB from four sub-municipal treatment centres were included in the study.

PRIMARY OUTCOME MEASURE

A logistic regression model was used to investigate the relationship between clinico-demographic factors (age, sex, type of patient, disease classification, treatment category and sputum smear microscopy) and TB-HIV coinfection.

RESULTS

Of the 462 individual TB cases found in the TB register from 2010 to 2020, 286 (61.9%) were screened for HIV and the results showed that 18% had TB-HIV coinfection. TB-HIV coinfection was highest in 2015 with a prevalence of 40% among all registered TB cases. The likelihood of TB-HIV coinfection was highest among patients with TB aged 40-49 years (AOR=3.99, CI=1.3, 12.7). Those who tested negative for TB at the end of their treatment period had lower odds of HIV coinfection (AOR=0.27, CI=0.10, 0.72).

CONCLUSION

Nearly one out of every five (18%) patients with TB in the municipality were found to be coinfected with HIV. TB-HIV coinfection was significantly associated with patients' age and their TB treatment outcomes. Urgent interventions are needed to address these risk factors to promote optimal health for patients with TB in the municipality.

摘要

目的

评估加纳结核病(TB)-人类免疫缺陷病毒(HIV)合并感染的流行率、治疗结局和决定因素。

研究设计

对夸布雷东市 2010 年至 2020 年的结核病病例登记进行回顾性审查,以确定结核病 - 人类免疫缺陷病毒合并感染。

研究地点

该研究纳入了来自四个分区治疗中心的 462 名结核病患者。

主要观察指标

使用逻辑回归模型调查临床 - 人口统计学因素(年龄、性别、患者类型、疾病分类、治疗类别和痰涂片显微镜检查)与结核病 - 人类免疫缺陷病毒合并感染之间的关系。

结果

在 2010 年至 2020 年的结核病登记处发现的 462 例个体结核病病例中,286 例(61.9%)接受了 HIV 筛查,结果显示 18%有结核病 - 人类免疫缺陷病毒合并感染。在所有登记的结核病病例中,2015 年结核病 - 人类免疫缺陷病毒合并感染率最高,为 40%。40-49 岁的结核病患者合并感染结核病 - 人类免疫缺陷病毒的可能性最高(AOR=3.99,CI=1.3,12.7)。在治疗期末检测出结核病阴性的患者感染 HIV 的可能性较低(AOR=0.27,CI=0.10,0.72)。

结论

在该市,近五分之一(18%)的结核病患者被发现合并感染 HIV。结核病 - 人类免疫缺陷病毒合并感染与患者年龄及其结核病治疗结局显著相关。需要采取紧急干预措施来解决这些风险因素,以促进该市结核病患者的最佳健康。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/541e/10040042/5997d3b70464/bmjopen-2022-067613f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/541e/10040042/3783d1eee050/bmjopen-2022-067613f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/541e/10040042/5997d3b70464/bmjopen-2022-067613f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/541e/10040042/3783d1eee050/bmjopen-2022-067613f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/541e/10040042/5997d3b70464/bmjopen-2022-067613f02.jpg

相似文献

1
Prevalence, treatment outcomes and determinants of TB-HIV coinfection: a 10-year retrospective review of TB registry in Kwabre East Municipality of Ghana.加纳夸贝东地区 10 年结核登记回顾性研究:结核-艾滋病毒合并感染的流行率、治疗结局和决定因素。
BMJ Open. 2023 Mar 22;13(3):e067613. doi: 10.1136/bmjopen-2022-067613.
2
The burden of HIV on Tuberculosis patients in the Volta region of Ghana from 2012 to 2015: implication for Tuberculosis control.2012年至2015年加纳沃尔特地区艾滋病毒对结核病患者的负担:对结核病控制的影响。
BMC Infect Dis. 2017 Jul 19;17(1):504. doi: 10.1186/s12879-017-2598-z.
3
Factors influencing treatment default among tuberculosis patients in a high burden province of South Africa.南非高负担省份结核病患者治疗缺漏的影响因素
Int J Infect Dis. 2017 Jan;54:95-102. doi: 10.1016/j.ijid.2016.11.407. Epub 2016 Nov 25.
4
Home-Based and Facility-Based Directly Observed Therapy of Tuberculosis Treatment under Programmatic Conditions in Urban Tanzania.坦桑尼亚城市地区在项目条件下对结核病治疗进行的居家和医疗机构直接督导下的治疗
PLoS One. 2016 Aug 11;11(8):e0161171. doi: 10.1371/journal.pone.0161171. eCollection 2016.
5
Childhood tuberculosis and factors associated with mortality and loss to follow-up at a major paediatric treatment centre in Southern Ghana.加纳南部一家主要儿科治疗中心的儿童结核病及与死亡率和失访相关的因素。
Pan Afr Med J. 2022 Oct 19;43:90. doi: 10.11604/pamj.2022.43.90.35440. eCollection 2022.
6
Predictors of unfavourable tuberculosis treatment outcome in Bilene District, Gaza Province, Mozambique: A retrospective analysis, 2016 - 2019.预测莫桑比克加扎省比莱内地区不利的结核病治疗结果:2016-2019 年回顾性分析。
S Afr Med J. 2022 Mar 2;112(3):234-239.
7
Burden of HIV and treatment outcomes among TB patients in rural Kenya: a 9-year longitudinal study.肯尼亚农村地区结核病患者中的艾滋病毒负担和治疗结局:一项为期 9 年的纵向研究。
BMC Infect Dis. 2023 May 30;23(1):362. doi: 10.1186/s12879-023-08347-0.
8
Factors associated with mortality and default among patients with tuberculosis attending a teaching hospital clinic in Accra, Ghana.加纳阿克拉一家教学医院门诊就诊的结核病患者的死亡和失访相关因素。
Trans R Soc Trop Med Hyg. 2011 Dec;105(12):675-82. doi: 10.1016/j.trstmh.2011.07.017. Epub 2011 Sep 13.
9
Epidemiology and treatment outcomes of recurrent tuberculosis in Tanzania from 2018 to 2021 using the National TB dataset.2018 年至 2021 年坦桑尼亚国家结核病数据集显示的复发性结核病的流行病学和治疗结果。
PLoS Negl Trop Dis. 2024 Feb 15;18(2):e0011968. doi: 10.1371/journal.pntd.0011968. eCollection 2024 Feb.
10
Tuberculosis Treatment Outcomes Among HIV/TB-Coinfected Children in the International Epidemiology Databases to Evaluate AIDS (IeDEA) Network.国际评估艾滋病流行病学数据库(IeDEA)网络中艾滋病毒/结核病合并感染儿童的结核病治疗结果
J Acquir Immune Defic Syndr. 2017 Jun 1;75(2):156-163. doi: 10.1097/QAI.0000000000001335.

引用本文的文献

1
Geospatial Distribution of Tuberculosis Incidence and Determinants of Tuberculosis Treatment Outcomes in Nzema East Municipality, Ghana.加纳恩泽马东区结核病发病率的地理空间分布及结核病治疗结果的决定因素
Public Health Chall. 2025 Aug 12;4(3):e70108. doi: 10.1002/puh2.70108. eCollection 2025 Sep.
2
High prevalence of co-infections with latent tuberculosis, syphilis and hepatitis B and C among people with HIV in Ghana: a call for integrating screening into routine care.加纳艾滋病毒感染者中潜伏性结核病、梅毒以及乙型和丙型肝炎合并感染的高流行率:呼吁将筛查纳入常规护理。
AIDS Res Ther. 2025 Jun 10;22(1):61. doi: 10.1186/s12981-025-00756-2.
3

本文引用的文献

1
Global Tuberculosis Report 2020 - Reflections on the Global TB burden, treatment and prevention efforts.2020 年全球结核病报告——对全球结核病负担、治疗和预防工作的反思。
Int J Infect Dis. 2021 Dec;113 Suppl 1(Suppl 1):S7-S12. doi: 10.1016/j.ijid.2021.02.107. Epub 2021 Mar 11.
2
Evaluation of TB/HIV Collaborative Activities: The Case of South Tongu District, Ghana.结核病/艾滋病协作活动评估:以加纳南通古区为例。
Tuberc Res Treat. 2020 May 22;2020:4587179. doi: 10.1155/2020/4587179. eCollection 2020.
3
Bayesian modeling of spatiotemporal patterns of TB-HIV co-infection risk in Kenya.
Prevalence and predictors of unsuccessful tuberculosis treatment outcomes among persons with TB/HIV co-infection in Ghana: a 10-year retrospective study.
加纳结核病/艾滋病病毒合并感染患者结核病治疗结果未成功的患病率及预测因素:一项10年回顾性研究
BMC Infect Dis. 2025 May 6;25(1):669. doi: 10.1186/s12879-025-11054-7.
4
Prevalence and determinants of TB/HIV coinfection: the double tragedy of infectious disease burden - a 5-year retrospective study in a tertiary health facility in Enugu State, Nigeria.结核分枝杆菌/艾滋病病毒合并感染的流行情况及决定因素:传染病负担的双重悲剧 - 尼日利亚埃努古州一家三级医疗机构的 5 年回顾性研究。
BMJ Open. 2024 Nov 28;14(11):e088287. doi: 10.1136/bmjopen-2024-088287.
5
Replicative co-infections with human immunodeficiency virus 1 and 2 as well as hepatitis B and C virus in Ghanaian individuals.加纳个体中人类免疫缺陷病毒1型和2型以及乙型和丙型肝炎病毒的复制性合并感染。
Eur J Microbiol Immunol (Bp). 2024 Oct 30;14(4):346-360. doi: 10.1556/1886.2024.00103. Print 2024 Dec 18.
6
Prevalence, treatment outcomes and determinants of TB/HIV coinfection: A 4-year retrospective review of national tuberculosis registry in a country in a MENA region.结核病/艾滋病病毒合并感染的患病率、治疗结果及决定因素:对中东和北非地区某国国家结核病登记处的4年回顾性研究。
Heliyon. 2024 Feb 17;10(5):e26615. doi: 10.1016/j.heliyon.2024.e26615. eCollection 2024 Mar 15.
7
How We Treat Drug-Susceptible Pulmonary Tuberculosis: A Practical Guide for Clinicians.我们如何治疗药物敏感型肺结核:临床医生实用指南
Antibiotics (Basel). 2023 Dec 14;12(12):1733. doi: 10.3390/antibiotics12121733.
肯尼亚结核-艾滋病毒合并感染风险时空模式的贝叶斯建模。
BMC Infect Dis. 2019 Oct 28;19(1):902. doi: 10.1186/s12879-019-4540-z.
4
Treatment outcomes and antiretroviral uptake in multidrug-resistant tuberculosis and HIV co-infected patients in Sub Saharan Africa: a systematic review and meta-analysis.撒哈拉以南非洲地区耐多药结核病和 HIV 合并感染患者的治疗结局和抗逆转录病毒药物的使用情况:系统评价和荟萃分析。
BMC Infect Dis. 2019 Aug 16;19(1):723. doi: 10.1186/s12879-019-4317-4.
5
Combining surveillance systems to investigate local trends in tuberculosis-HIV co-infection.整合监测系统以调查结核病-艾滋病病毒合并感染的局部趋势。
AIDS Care. 2019 Oct;31(10):1311-1318. doi: 10.1080/09540121.2019.1576845. Epub 2019 Feb 7.
6
Predictors of mortality among intensive care unit patients coinfected with tuberculosis and HIV.同时感染结核病和艾滋病病毒的重症监护病房患者的死亡预测因素。
J Bras Pneumol. 2018 Apr;44(2):118-124. doi: 10.1590/s1806-37562017000000316.
7
Preventing tuberculosis in people with HIV-no more excuses.预防艾滋病毒感染者的结核病——别再找借口了。
Lancet Glob Health. 2017 Nov;5(11):e1048-e1049. doi: 10.1016/S2214-109X(17)30390-X.
8
The burden of HIV on Tuberculosis patients in the Volta region of Ghana from 2012 to 2015: implication for Tuberculosis control.2012年至2015年加纳沃尔特地区艾滋病毒对结核病患者的负担:对结核病控制的影响。
BMC Infect Dis. 2017 Jul 19;17(1):504. doi: 10.1186/s12879-017-2598-z.
9
Tuberculosis: a disease without boundaries.结核病:一种无国界的疾病。
Tuberculosis (Edinb). 2015 Sep;95(5):527-31. doi: 10.1016/j.tube.2015.05.017. Epub 2015 Jun 25.
10
The WHO 2014 global tuberculosis report--further to go.《世界卫生组织2014年全球结核病报告》——仍任重道远。
Lancet Glob Health. 2015 Jan;3(1):e10-2. doi: 10.1016/S2214-109X(14)70361-4.